secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001104659-23-063162
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood to acquire VectivBio for $17.00/share; secures $500M credit facility
-----------------------------------------------------------------------------

- Cash tender offer at $17.00/share for all VectivBio shares; minimum tender condition >80%.
- Termination fees: VectivBio pays $23.68M if superior proposal; Ironwood pays $59.2M reverse fee.
- $500M revolving credit facility from Wells Fargo; matures 2027; secured by substantially all assets.
- Support agreement with shareholders owning ~28.6% of VectivBio shares agreeing to tender and vote.
- VectivBio shareholders must remove voting cap and elect Ironwood designees to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/0001104659-23-063162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/tm2316415d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-063162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer